Mackenzie Shindorf

Mackenzie Shindorf practices at Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation.

Mackenzie Shindorf's NPI, 1801215116, was assigned on April 15, 2014. Mackenzie Shindorf holds Ohio license 35.130387.

Mackenzie Shindorf's primary practice is Cleveland Clinic Akron General, at 1 Akron General Avenue, Akron, OH 44307 in Summit County. The practice phone is (330) 344-6000.

Mackenzie Shindorf's primary practice is Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation. Mackenzie Shindorf is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Partners Physician Group. Dmand AI also links Mackenzie Shindorf to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mackenzie Shindorf practices, 5 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Mackenzie Shindorf's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Mackenzie Shindorf is licensed in Ohio.

CMS counts 30 Medicare patients who saw Mackenzie Shindorf in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mackenzie Shindorf's median patient age at 64, with 54% women.

In 2024, Mackenzie Shindorf wrote 13 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $26 in total drug cost. In 2016, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Mackenzie Shindorf for performance year 2024, reported through an alternative payment model (APM). Mackenzie Shindorf accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mackenzie Shindorf as offering telehealth. CMS counts 19 procedures of melanoma (skin cancer) excision by Mackenzie Shindorf, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Mackenzie Shindorf, published from 2013 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Lymphocytes, Tumor-Infiltrating, Antigens, Neoplasm and Fellowships and Scholarships. Mackenzie Shindorf has published most often in Clin Cancer Res. Mackenzie Shindorf's most frequent co-authors are Stephanie Lynn Goff, MD, Andrew Blakely, MD and James Dallas McDonald, MD.

CMS Open Payments shows 22 general payments to Mackenzie Shindorf from 11 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $183.